Loading…
Fennec Pharmaceuticals Inc. is projected to rise to $13.31 by 2027, a +34% move from its current price of $9.97. FENC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.67 | $9.98 | $10.29 | +0.06% |
| May 30 | $9.55 | $9.98 | $10.43 | +0.11% |
| May 31 | $9.46 | $9.99 | $10.54 | +0.17% |
| Jun 1 | $9.39 | $9.99 | $10.63 | +0.22% |
| Jun 2 | $9.33 | $10.00 | $10.72 | +0.28% |
| Jun 3 | $9.27 | $10.00 | $10.80 | +0.33% |
| Jun 4 | $9.22 | $10.01 | $10.87 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.22 | $10.01 | $10.87 | +0.39% |
| Week 2 | $8.94 | $10.05 | $11.29 | +0.78% |
| Week 3 | $8.75 | $10.09 | $11.63 | +1.17% |
| Week 4 | $8.59 | $10.13 | $11.94 | +1.56% |
| Week 5 | $8.46 | $10.16 | $12.22 | +1.96% |
| Week 6 | $8.34 | $10.20 | $12.48 | +2.35% |
| Week 7 | $8.24 | $10.24 | $12.74 | +2.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients.
It sells its products through regional pediatric oncology specialists and medical science liaisons.
Fennec has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc.
and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Fennec Pharmaceuticals Inc. (FENC) is the asset. The current price is $9.93 and the market cap is $344.94M, with a rank of 3379.
The stock trades at $9.93 and has a market cap of $344.94M, ranking 3379 by market cap. The 30-day range is $7.99-$12.35. The forecast points to a long-run upside, with the average price rising over time: 2026 avg $9.93, 2030 avg $17.69, and 2050 avg $108.86.
Near term sentiment is neutral for 2026, shifting to bullish in subsequent years, with an upward trajectory in the forecasted average prices across the horizon.
A major floor 49.6% below — a decisive break under it would weaken the trend.
The nearest floor, 37.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 24.8% above — clearing it would confirm fresh momentum.
Key FENC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FENC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.90 | Buy | $9.82 | Buy |
| MA 10 | $9.46 | Buy | $9.35 | Buy |
| MA 20 | $8.12 | Buy | $8.57 | Buy |
| MA 50 | $7.19 | Buy | $7.79 | Buy |
| MA 100 | $7.56 | Buy | $7.66 | Buy |
| MA 200 | $7.98 | Buy | $7.67 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.75 | Sell |
| Stoch RSI (14) | 94.76 | Sell |
| CCI (20) | 83.45 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.21 | Buy |
| ROC (12) | 43.87 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.36 | Buy |
| Awesome (5,34) | 2.45 | Buy |
| Ultimate (7,14,28) | 71.55 | Sell |
| Momentum (10) | 2.94 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 10.06 | Sell |
| ADX (14) | 30.09 | Buy |
| ATR (14) | 0.26 | Info |
The near-term technical picture is bullish on a broad view, with RSI14 at 80 and price momentum supported by moving averages. The SMA50 stands at $7.10 and the SMA200 at $7.97, placing the current price above both averages and near key levels.
Support is reported at $5.93 and resistance at $9.97, with the 30-day range between $7.99 and $12.35. This configuration suggests potential upside if resistance is cleared, while a move below support could indicate renewed downside risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.77 | $9.97 | $15.84 | 0% | Neutral | |
| $10.41 | $13.31 | $18.11 | +34% | Bullish | |
| $12.17 | $16.05 | $22.73 | +61% | Bullish | |
| $12.72 | $17.22 | $25.16 | +73% | Bullish | |
| $13.10 | $18.17 | $27.25 | +82% | Bullish | |
| $15.37 | $21.77 | $33.42 | +118% | Bullish | |
| $17.64 | $25.50 | $39.96 | +156% | Bullish | |
| $21.66 | $31.91 | $50.96 | +220% | Bullish | |
| $24.23 | $36.35 | $59.07 | +265% | Bullish | |
| $23.21 | $35.44 | $58.52 | +255% | Bullish | |
| $37.25 | $61.59 | $108.77 | +518% | Bullish | |
| $60.66 | $115.35 | $224.54 | +10.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.77 | $9.97 | $11.69 | +0.00% |
| June 2026 | $8.42 | $9.91 | $11.98 | -0.56% |
| July 2026 | $8.82 | $10.49 | $12.86 | +5.77% |
| August 2026 | $9.16 | $10.98 | $13.62 | +4.67% |
| September 2026 | $9.19 | $11.08 | $13.88 | +0.92% |
| October 2026 | $9.50 | $11.53 | $14.57 | +4.06% |
| November 2026 | $10.02 | $12.22 | $15.56 | +5.97% |
| December 2026 | $10.08 | $12.35 | $15.84 | +1.11% |
Click any year to see its month-by-month FENC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The FENC price prediction for 2026 points to an average of $9.97 (low $5.77, high $15.84) — a potential gain of 0% on today's $9.97. A consolidation phase looks the most probable path here.
In 2027, FENC is projected to trade between $10.41 and $18.11, averaging $13.31 — a potential gain of +34% from today's $9.97. That is up +34% on the projected 2026 average. Momentum favours further upside here.
Fennec Pharmaceuticals Inc.'s 2028 outlook centres on $16.05, within a $12.17 to $22.73 range. That is up +21% on the projected 2027 average. That marks a +61% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, FENC could reach as high as $25.16, with a base case around $17.22 and support toward $12.72 — roughly +73% from $9.97. Momentum favours further upside here.
Expect FENC to range from $13.10 to $27.25 through 2030. The $18.17 average target implies a +82% move from current prices. That is up +5% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The FENC price prediction for 2031 points to an average of $21.77 (low $15.37, high $33.42) — a potential gain of +118% on today's $9.97. Momentum favours further upside here.
In 2032, FENC is projected to trade between $17.64 and $39.96, averaging $25.50 — a potential gain of +156% from today's $9.97. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Fennec Pharmaceuticals Inc.'s 2033 outlook centres on $31.91, within a $21.66 to $50.96 range. That is up +25% on the projected 2032 average. That marks a +220% change versus current levels. Momentum favours further upside here.
By 2034, FENC could reach as high as $59.07, with a base case around $36.35 and support toward $24.23 — roughly +265% from $9.97. Buyers look set to stay in control over this stretch.
Expect FENC to range from $23.21 to $58.52 through 2035. The $35.44 average target implies a +255% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The FENC price prediction for 2040 points to an average of $61.59 (low $37.25, high $108.77) — a potential gain of +518% on today's $9.97. Buyers look set to stay in control over this stretch.
In 2050, FENC is projected to trade between $60.66 and $224.54, averaging $115.35 — a potential gain of +10.6x from today's $9.97. That is up +87% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in FENC today (≈ 100.300903 FENC) could be worth
$11,569.56
+$10,569.56 (+1057%) by 2050 · US Dollar
Based on the average projected FENC price of $115.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FENCwould be worth at today's price.
$1,000 invested in FENC on May 27, 2025 (≈ 123.001228 FENC) would be worth
$1,226.32
+$226.32 (+22.6%) today · 1.23× · US Dollar
Based on a FENC entry price of $8.13 vs. today's $9.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.75 | $1,022.56 | +2.3% |
| 1 month ago | $6.85 | $1,455.47 | +45.5% |
| 3 months ago | $8.61 | $1,157.96 | +15.8% |
| 6 months ago | $8.19 | $1,217.34 | +21.7% |
| 1 year ago | $8.13 | $1,226.32 | +22.6% |
| All time (5.0y) ago | $7.53 | $1,324.04 | +32.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FENC forecast.
Our base-case forecast reaches $20.00 around 2031.
Implied market cap at $20.00: $694.74M
The multi-year forecast shows a pronounced bullish trajectory, with the 2030 average price at $17.69 and the 2040 average at $59.62, rising further to $108.86 by 2050. The corresponding ROI figures illustrate substantial upside: 78.1% by 2030, 500.4% by 2040, and 996.3% by 2050, with sentiment remaining BULLISH across most years.
In 2026 the forecast is Neutral with an average of $9.93, then progressively stronger into the late 2020s and into the 2030s and beyond. The forecast highlights a long-run appreciation potential, but these are estimates and not guarantees, subject to market conditions and other factors.
Tap a question to reveal the answer.
Avg $17.69; Min $12.59; Max $26.91; ROI 78.1%; Sentiment BULLISH. These are estimates, not guarantees.
Forecast shows a long-run bullish trajectory with 2027 avg $13.23, 2030 avg $17.69, 2040 avg $59.62, and 2050 avg $108.86; ROI rises to 78.1% by 2030 and 996.3% by 2050. These figures are estimates and not guarantees.
Yes, the 2050 average is $108.86 and the 2050 max is $217.28, indicating potential to exceed $100, though these are forecasted estimates and not guaranteed.
The 30-day range is $7.99 to $12.35.
Current price is $9.93 and market cap is $344.94M.
Fennec Pharmaceuticals Inc. Community Discussion
0Share your Fennec Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.